Puma Biotechnology, Inc. (PBYI)
10.50
-0.04
(-0.38%)
USD |
NASDAQ |
Oct 30, 13:17
Puma Biotechnology Cash and Short Term Investments (Annual) : 99.62M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 99.62M |
| December 31, 2024 | 100.96M |
| December 31, 2023 | 95.94M |
| December 31, 2022 | 81.07M |
| December 31, 2021 | 90.96M |
| December 31, 2020 | 102.24M |
| December 31, 2019 | 120.49M |
| December 31, 2018 | 165.42M |
| Date | Value |
|---|---|
| December 31, 2017 | 81.70M |
| December 31, 2016 | 229.48M |
| December 31, 2015 | 215.89M |
| December 31, 2014 | 141.33M |
| December 31, 2013 | 83.95M |
| December 31, 2012 | 137.41M |
| December 31, 2011 | 53.38M |
| December 31, 2010 | 0.0005M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Olema Pharmaceuticals, Inc. | 505.44M |
| Anika Therapeutics, Inc. | 57.48M |
| Arcutis Biotherapeutics, Inc. | 221.29M |
| ACADIA Pharmaceuticals, Inc. | 819.69M |
| Alnylam Pharmaceuticals, Inc. | 2.908B |